Wearable brain sensors aim to perfect seizure drug dosing at home
NCT ID NCT07225231
First seen Nov 06, 2025 · Last updated May 20, 2026 · Updated 28 times
Summary
This study tests whether a wearable home monitoring system (EEG, heart rate, breathing) helps doctors feel more confident when adjusting the dose of fenfluramine for people with Dravet or Lennox-Gastaut syndrome. Twenty patients aged 3 and up will wear the devices for 3–7 days at a time, three times total. The goal is to see if the extra data improves treatment decisions compared to standard care alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRAVET SYNDROME (DS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.